Benzoyl 2-methyl indoles as selective PPARγ modulators
Graphical abstract
A series of selective PPARγ modulators (SPPARγMs) and their development from hPPARγ active screening leads 1 and 2 is described. SPPARγM 24 displayed robust anti-diabetic activity with an improved therapeutic window in comparison to a PPARγ full agonist in a rodent efficacy model.
Section snippets
Acknowledgements
We are indebted to Dr. Peter Meinke for critical reading of this manuscript. We also wish to acknowledge the skills and hard work of the many scientists who provided biological support including Margaret Wu, John Ventre, Roger Meurer, Neelam Sharma, Chhabi Biswas, Raul Alvaro, and Zhesheng Chen.
References and notes (22)
- et al.
Trends Endocrinol. Metab.
(2000)et al.Diabetes Technol. Ther.
(2002)et al.Annu. Rev. Med.
(2002) - et al.
J. Med. Chem.
(1994) - et al.
Mol. Endocrinol.
(2000) - et al.
Bioorg. Med. Chem. Lett.
(1999) - et al.
Tetrahedron Lett.
(1992) - et al.
J. Biol. Chem.
(1999) - et al.
Endocrinology
(1996) - et al.
Cell
(1994) - et al.
Chem. Pharm. Bull.
(1991)
EMBO Rep.
Expert Opin. Investig. Drugs
Cited by (126)
Indazole MRL-871 interacts with PPARγ via a binding mode that induces partial agonism
2022, Bioorganic and Medicinal ChemistryResearch progress of indole compounds with potential antidiabetic activity
2021, European Journal of Medicinal ChemistryCitation Excerpt :Among 23 newly synthesized derivatives, 54 exhibited the potent antidiabetic activity as a PPARγ modulator with good selectivity. More importantly, the activity of 54 was superior to the standard agonist rosiglitazone in pharmacologic action, which could be used as a lead compound in new antidiabetic drug development [64]. Khalaf et al. designed and synthesized several simple derivatives in 2015 by combining tryptophan with thiosemicarbazide, as shown in Scheme 38.
Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis
2020, Cell Reports MedicineAn insight into the medicinal perspective of synthetic analogs of indole: A review
2019, European Journal of Medicinal ChemistryFriedel-Crafts alkylation of indoles with trichloroacetimidates
2019, Tetrahedron Letters
- †
Present address: Merck Research Laboratories, Terlings Park, United Kingdom.